Francis Gigliotti
Affiliations: | University of Rochester, Rochester, NY |
Area:
Microbiology Biology, ImmunologyGoogle:
"Francis Gigliotti"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hoy Z, Wright TW, Elliott M, et al. (2019) Combination immunotherapy with passive antibody and sulfasalazine accelerates fungal clearance and promotes the resolution of associated immunopathogenesis. Infection and Immunity |
Bhagwat SP, Gigliotti F, Wang J, et al. (2018) Intrinsic Programming of Alveolar Macrophages for Protective Antifungal Innate Immunity Against Infection. Frontiers in Immunology. 9: 2131 |
Tesini BL, Wright TW, Malone JE, et al. (2016) Immunization with Pca1 protects mice against Pneumocystis pneumonia and generates antibody to Pneumocystis jirovecii. Infection and Immunity |
Zhang ZQ, Wang J, Hoy Z, et al. (2015) Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome. Infection and Immunity |
Bello-Irizarry SN, Wang J, Johnston CJ, et al. (2014) MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection. Journal of Immunology (Baltimore, Md. : 1950). 192: 282-92 |
Perez-Nazario N, Rangel-Moreno J, O'Reilly MA, et al. (2013) Selective ablation of lung epithelial IKK2 impairs pulmonary Th17 responses and delays the clearance of pneumocystis Journal of Immunology. 191: 4720-4730 |
Gigliotti F, Wright TW. (2012) Pneumocystis: Where Does It Live? Plos Pathogens. 8 |
Bello-Irizarry SN, Wang J, Olsen K, et al. (2012) The alveolar epithelial cell chemokine response to Pneumocystis requires adaptor molecule MyD88 and interleukin-1 receptor but not toll-like receptor 2 or 4 Infection and Immunity. 80: 3912-3920 |
Wang J, Gigliotti F, Bhagwat SP, et al. (2010) Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia. Plos Pathogens. 6: e1001058 |
Bhagwat SP, Wright TW, Gigliotti F. (2010) Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia Journal of Immunology. 184: 497-502 |